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Objectives. This study sought to determine whether microvas-
cular integrity in the risk area (RA) for myocardial infarction
(MI) one day after recanalization predicts the outcome in patients
with first acute MI.
Background. Immediately after recanalization, microcircula-
tion in the RA is modified by both hyperemic response and
microvascular impairment.
Methods. Fifty consecutive patients who underwent serial myo-
cardial contrast echocardiography before and one day after
recanalization (day 2) were studied. All patients had a completely
occluded lesion in the left anterior descending coronary artery
alone, and underwent successful reperfusion therapy. The relative
size of the initial RA (RA ratio) and peak gray scale ratio (PGSR)
within the RA on day 2 were determined. Patients were followed
for a median of 22 months to evaluate clinical outcome.
Results. On day 2, PGSR was a median of 0.46. Study patients
were subdivided into two groups, group A of 24 patients with
acceptable opacification (PGSR > 0.46 on day 2) and group B of
26 patients without it. Major cardiac events (cardiac death,
nonfatal MI and repeat admission for congestive heart failure)
were more frequently observed in group B (28% vs. 4%, Cox
hazard ratio 5 8.5, p 5 0.05, 95% confidence interval [CI] 1.03 to
69.9). The median value of the RA ratio was 0.45. Patients (n 5
15) with RA ratio > 0.45 on day 1 and PGSR on day 2 <2 0.46
exhibited a 10.7-fold relative risk for major cardiac events (p 5
0.005, 95% CI 2.06 to 55.8) and a 3.69-fold relative risk for
composite cardiac events (major cardiac events and target lesion
revascularizations) after the initial intervention (p 5 0.004, 95%
CI 1.51 to 9.04).
Conclusions. The assessment of both the size of the initial RA
and microvascular integrity on day 2 enables precise determina-
tion of the efficacy of reperfusion therapy and prediction of the
short- and intermediate-term prognoses of patients with recana-
lized MI.
(J Am Coll Cardiol 1998;32:890–7)
©1998 by the American College of Cardiology
During the last two decades, the efficacy of reperfusion therapy
for acute myocardial infarction (MI) has been established (1),
yet the degree of myocardial salvage after recanalizing culprit
lesions varies from patient to patient (2). It is therefore
necessary to evaluate myocardial viability during the acute
stage, and to administer aggressive treatment for the antici-
pated left ventricular hemodynamic and structural changes
based on individual patient cardiac condition. Several methods
are available for evaluation of salvaged myocardial viability in
the acute stage, including positron emission tomography (3)
and myocardial scintigraphy (4). However, these methods may
not always be available in the catheterization laboratory and
are expensive. Myocardial contrast echocardiography (MCE)
can easily be performed in the catheterization laboratory
during the acute stage of MI and is reported to be one of the
most promising methods for assessing microvascular integrity
and consequent myocardial viability in the convalescent stage
of MI.
The in-hospital prognoses of patients in whom angiographic
no-reflow phenomena are observed immediately after reper-
fusion is unfavorable (5). Left ventricular function in patients
with no-reflow phenomena detected using MCE is impaired in
the chronic stage (6), in-hospital complications are frequent in
such patients (7) and lack of reflow phenomena after initial
reperfusion therapy is one of the predictors of left ventricular
remodeling (7). However, microcirculation in the entire risk
area (RA) changes rapidly immediately after reperfusion. In a
previous study using serial MCEs (8), although we found no
significant correlation between microvascular integrity imme-
diately after recanalization and that in the convalescent stage
of MI, we did find that microvascular integrity one day after
recanalization was closely related to that in the convalescent
stage. Thus, MCE one day after recanalization appears to
enable the prediction of both the short- and intermediate-term
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prognoses of patients who have suffered acute MI. Neverthe-
less, the clinical prognoses of patients who have suffered a first
acute MI and for whom serial MCE was performed during the
acute phase has not been clearly determined. The present
study was therefore designed to determine whether serial
assessments of microvascular integrity in the RA for MI before
and up to one day after recanalization of the culprit lesion are
useful for predicting the short- and intermediate-term out-
comes of patients who have experienced a first acute anterior
or anteroseptal MI.
Methods
Study population. The study population consisted of 50
consecutive patients (32 men and 18 women) ranging from 44
to 88 years of age (mean, 66 years) who were admitted to the
Coronary Care Unit at Tsuchiya General Hospital with the
diagnosis of a first acute anterior or anteroseptal MI, and who
underwent serial MCE examination before and immediately
after successful recanalization and one day thereafter. They
were prospectively selected for this study if they met the
following criteria between February 1993 and April 1995:
cardiopulmonary condition on arrival corresponded to Killip
classification I, II or III; the culprit lesion for acute MI was
located in the sixth or seventh segment as defined by the
American Heart Association Committee Report (9); single-
vessel coronary artery disease was present; Thrombolysis In
Myocardial Infarction trial (TIMI) grade 0 or I flow was
confirmed on multidirectional coronary angiography after se-
lective infusion of 5 mg isosorbide dinitrate; collateral circula-
tion feeding the infarct-related coronary artery (IRA) on the
initial angiogram corresponded to Rentrop collateral filling
grade 0, I or II (10); recanalization achieved TIMI grade II or
grade III flow without $70% diameter residual stenosis on
multidirectional observation by quantitative coronary angiog-
raphy within 24 h after the onset of symptoms; technically
adequate two-dimensional echocardiographic images were ob-
tained for MCE; and informed consent could be obtained from
them or from their families.
Definitive diagnosis of acute MI was made based on the
following criteria: chest pain lasting for more than 30 min;
ST-segment elevation in at least two consecutive anterior leads
on electrocardiographic examination; regional anterior or an-
teroseptal wall motion abnormalities observed in the territory
of the left anterior descending coronary artery (LAD) on
two-dimensional echocardiograms; and confirmation of the
diagnosis by a typical pattern of increase and decrease over
time in total creatine phosphokinase.
During the period for enrollment of eligible patients, 149
consecutive patients with acute anterior or anteroseptal MI
underwent emergent coronary angiography. Following exclu-
sions, 66 patients remained. However, no informed written
consent could be obtained from five of these patients. Of the
remaining 61 patients, no repeat coronary angiograms or
MCEs were performed for 4 on the second hospital day, in 1
case due to pneumonia, in 2 cases to cerebral vascular acci-
dent, and in 1 case to acute renal insufficiency. For seven other
patients, inadequate image quality was obtained for analysis
with our off-line computer system. Thus, a total of 50 patients
were finally enrolled for this cohort study.
Angiographic study and MCE. On the first hospital day,
emergent coronary angiography was performed following ad-
mission. Selective coronary angiography was performed using
the Seldinger technique after intravenous injection of 50 U/kg
heparin, and multiple projections including at least two orthog-
onal angiographic views with minimal vessel overlaps were
recorded at 30 frames/s. Provided that patients did not have
severe congestive heart failure, that is, pulmonary capillary
wedge pressure less than 18 mm Hg as measured using a
Swan–Ganz catheter inserted via the femoral vein, left ven-
triculograms in the 30° right anterior oblique plane were
obtained prior to recanalization. After confirming occlusion of
the proximal portion of the LAD, MCEs were performed prior
to recanalization, as follows. MCE was performed by selective
intracoronary injection of 2 ml sonicated ioxaglic acid
(Hexabrix-320, Tanabe, Osaka, Japan) generated using an
ultrasonic homogenizer (Model 250, Sonifier-II, Branson Ul-
trasonics Corporation, Danbury, Connecticut) at a rate of 1
ml/s with a 5F diagnostic catheter. Sonicated microbubbles
were generated by sonicating the contrast agent at 50 watts for
30 s (11).
The mean diameter of the sonicated ioxaglic acid was
measured using computed planimetry. The size of micro-
bubbles was microscopically compared with that of polybead
blue-dyed microspheres 10 mm in diameter (Polysciences, Inc.,
Warrington, Pennsylvania). The mean diameter was 10.3 6
3.9 mm (mean 6 SD). Two repeat two-dimensional echocar-
diographic images in the long apical view were recorded on
super-VHS video cassette tape using a high-fidelity video
recorder (Model SVO-9500MD, Sony, Tokyo, Japan) and a
phased-array system (Model SSD 870 Ultrasound Systems,
Aloka, Tokyo, Japan) with a 3.5-MHz transducer. We at-
tempted to visualize images formed by the plane defined
by three points, the junction of the mitral valve cusp, that of
the aortic valve cusp and the cardiac apex. The gain set-
tings and sensitivity time control were held constant through-
out the observations after adjusting for optimal identification
of the endocardium and epicardium. Once we had determined
Abbreviations and Acronyms
CABG 5 coronary artery bypass surgery
ECGs 5 electrocardiograms
IRA 5 infarct-related coronary artery
LAD 5 left anterior descending coronary artery
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PTCA 5 percutaneous transluminal coronary angioplasty
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the optimal settings for each patient, the same settings were
used on all occasions. We defined the RA for MI as a contrast
deficit in the end-diastolic phase in the territory of the LAD
observed after injection of the sonicated contrast media before
opening the IRA (12). After determination of the RA, throm-
bolytic therapy (intravenous or intracoronary infusion of
tissue-type plasminogen activator, or intracoronary infusion of
urokinase) or primary percutaneous transluminal coronary
angioplasty (PTCA) was performed. For patients in whom
TIMI grade II or grade III flow could not be obtained with
thrombolytic therapy alone, rescue PTCA was performed.
When PTCA was performed, bolus injection of heparin up to
a total amount of 10,000 U was added. Twelve-lead electro-
cardiograms (ECGs) were recorded before recanalization and
serially up to the end of the catheterization procedures. At the
time of recanalization of the culprit lesion, we carefully
observed whether reperfusion arrhythmias and/or ST-segment
re-elevation appeared. Reperfusion arrhythmia was defined as
the transient appearance of premature ventricular contrac-
tions, accelerated idioventricular rhythm, ventricular tachycar-
dia or ventricular fibrillation immediately after recanalization.
Significant transient ST-segment re-elevation at 60 ms after the
J point was defined as an increase in SST (sum of ST-segment
elevations in V1 through V6 of .5 mm immediately after
recanalization compared with that before re-establishment of
anterograde flow. Myocardial contrast echocardiographies
were performed immediately after successful recanalization
with a 5F diagnostic catheter. We attempted carefully to depict
the same outline as that in the initial examination of prereflow
MCE. Since remaining regions of pronounced narrowing de-
crease coronary flow reserve and maximum opacification in the
RA (13), we excluded patients with high-grade residual steno-
sis from this study from the first hospital day onward. Each
patient was in principle administered intravenous nitroglyc-
erin, intravenous heparin and oral aspirin after being trans-
ferred to the Coronary Care Unit. On the second hospital day,
coronary angiography was performed and MCE was repeated
using the same method as described above. In both convales-
cent (1 month after recanalization) and remote stages (6
months and/or 1 year after recanalization), whenever feasible,
coronary angiograms and left ventriculograms were obtained
again in a similar manner.
The study protocol was approved by the Institutional Re-
view Board of Akane Foundation Tsuchiya General Hospital.
The registered patients and/or their family received written
information concerning the study and gave informed consent
for participation.
Analysis of catheterization and MCE data. The coronary
angiograms were analyzed by an experienced operator using a
commercially available quantitative coronary angiographic
software program (POLY C2 LAR C2 D.C.I., Coronary Quan-
tification Software Package, Philips Medical Systems, The
Netherlands BV). Using the projection revealing the severest
stenosis, the minimal lumen diameter, reference coronary
artery dimensions and percent diameter stenosis were mea-
sured.
To evaluate the size and microvascular integrity of the RA,
we employed a commercially available off-line computer
(Macintosh Quadra 800, Apple Computer Japan, Inc., Tokyo,
Japan) equipped with a video capturing card (Quick Capture
Card, Data Translation Corporation, Marlboro, Massachu-
setts). The images at end-diastolic phase on electrocardio-
graphic monitoring were accumulated in the hard disk as
sequential memory media approximately 15 s prior to injection
of the sonicated medium and up to 1 min after injection.
Computed planimetry was used to measure the size of the
initial RA. A mean gray scale in both the RA and a region of
the posterior wall (as a control site) was computed using public
domain image analyzing software (i.e., NIH Image ver. 1.56),
excluding the endocardial and epicardial borders. After con-
verting composite signals into 640 3 480 38-bit format, we
analyzed the peak gray scale ratio (PSGR) within the RA
normalized to the peak gray scale of the left circumflex artery
area with subtraction of the baseline using the following
formulas (14): PGSR 5 A/X, A 5 BSPGS in RA, and X 5
BSPGS in LCX, where PGSR is the peak gray scale ratio,
BSPGS the baseline-subtracted peak gray scale value after
opening the IRA and LCX the region of interest in the
territory of the left circumflex coronary artery. For serial
measurements of PGSR, image analysis was performed after
the same outline as prereflow examination in the long apical
view was carefully delineated in each stage using the off-line
computer system. We defined the ratio of relative size of the
initial RA (RA ratio) as follows: RA ratio 5 RA in the
territory of LAD/total longitudinal cross-sectional area in
the apical long axial view of the left ventricle. The off-line
measurements of areas in regions of interest and gray scale
levels of intensity were determined as the means of values of
two measurements obtained by each of two independent
observers who were unaware of the other’s findings.
Left ventricular regional wall motion was assessed in each
case by the centerline method described by Sheehan et al. (15),
in which the mean value of the standard deviation of chord
length (i.e., SD/chord) was calculated using the normalized
chord length in the LAD region (from 10 to 66 in chords out
of 100 chords) in the end-diastolic perimeter of the left
ventricle.
Reproducibility of results of MCE analysis. To determine
the interinjection reproducibility of both peak contrast inten-
sity and the RA ratio, we compared the results obtained from
the analysis of 11 randomized paired injections performed at
4-min intervals. To assess interobserver and intraobserver
reproducibility, a subset of 22 contrast injections, selected at
random, was quantified by an independent observer and later
by the initial observer. The interinjection, intraobserver and
interobserver reproducibilities for peak contrast intensity in
RA were tested for absolute error (i.e., absolute value of the
peak gray scale on the second injection subtracted from that on
the first injection) and percent error (i.e., absolute error
divided by the peak gray scale on the first injection) (16). The
interinjection, intraobserver and interobserver absolute errors
in peak contrast intensity were 3.7 6 4.7, 3.3 6 2.8 and 4.0 6
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6.9 (mean 6 SD), respectively. The percent errors in peak
contrast intensity were 6.4 6 4.9%, 6.6 6 5.3% and 8.7 6 9.5%,
respectively. Similarly, the interinjection, intraobserver and
interobserver absolute errors in the RA ratio were 0.04 6 0.03,
0.03 6 0.02 and 0.05 6 0.03, respectively. The percent errors
were 6.5 6 5.8%, 5.4 6 4.8% and 7.8 6 6.5%, respectively.
Follow-up. The incidences of clinical events were deter-
mined at 6 and 12 months after hospital discharge and then
once a year thereafter. Follow-up data were obtained from
review of the patients’ hospital record, personal communica-
tion with the patients’ attending physicians and telephone
interviews. Follow-up data were obtained for all patients.
The clinical events included in patient outcome determina-
tion were cardiac death, nonfatal myocardial reinfarction,
repeat hospitalization for congestive heart failure (NYHA
class III or class IV) and target lesion revascularization. The
major cardiac events included cardiac death, nonfatal myocar-
dial reinfarction and repeat hospitalization for congestive
heart failure. The composite cardiac events included in deter-
mination of cardiac event-free survival were cardiac death,
nonfatal myocardial reinfarction, repeat hospitalization for
congestive heart failure and revascularization of the target
lesion. Cardiac death was defined as death due to coronary
artery disease. Myocardial reinfarction was confirmed by a
typical pattern of increase and decrease over time in total
creatine phosphokinase in association with the appearance of
new, pathologic Q waves. The revascularization procedures for
the target lesions were considered to include all PTCAs which
included routine balloon coronary angioplasty, directional
coronary atherectomy and metallic coronary artery stenting to
the initial culprit lesion in the IRA, and coronary artery bypass
surgery (CABG) involving the initial culprit lesions. If repeat
interventions were performed to eliminate the cause of myo-
cardial reinfarction or congestive heart failure, myocardial
reinfarction or repeat hospitalization for congestive heart
failure was recorded as the cardiac event. Follow-up angiog-
raphy was performed in principle at 6 months (actual range, 3
to 8 months) and 12 months (actual range, 9 to 14 months)
after the onset of symptoms of the initial MI. Restenosis was
defined as reduction greater than 50% of the initial gain
derived from PTCAs and/or thrombolytic therapy performed
on the first hospital day, with greater than 50% diameter
stenosis in the initial culprit lesion. Target lesion revascular-
izations at follow-up angiography were as a general rule
attempted for patients who exhibited recurrence of severe
narrowing with greater than 70% diameter stenosis on quan-
titative coronary angiography. For patients with stenosis be-
tween 50% to 70%, those were performed in accordance with
the decision of the physicians performing angioplasty blind to
MCE data or on the basis of ischemic change on treadmill
tests. Clinical follow-up events were studied in accordance with
the intention-to-treat principle. In-hospital events were in-
cluded in the analysis of follow-up events.
Statistical analysis. Results are given as mean values 6 SD
or as proportions. Continuous variables were compared using
Student’s t-test. Statistical analysis of discrete variables was
performed with the chi-square test, and the Fisher exact test
was used when appropriate. Correlations between two differ-
ent groups were expressed by Pearson’s correlation coefficient.
The significance of each correlation was determined, since the
normalized correlation coefficient depended on the t distribu-
tion. The individual effect of certain variables on cardiac
event-free survival was evaluated with the Cox proportional
hazard model. Using a stepwise selection process, variables
were entered, or removed, from the regression equation on the
basis of computed significance probability. When evaluating
cardiac events, only the first cardiac event (in patients with .1
event) was considered. Findings of p , 0.05 (two-sided) were
considered significant.
Results
Serial MCEs were performed 31 min (range: 25 to 36)
before opening of the IRA and 29 min (range: 13 to 39) after
recanalization, and 23 h (range: 18 to 28) after opening of the
IRA, on average. No clinical adverse effects of MCE proce-
dures were observed except for transient hypotension in two
patients. Peak gray scale ratio on the first hospital day was a
median of 0.33 (0.37 6 0.21), while PGSR on the second
hospital day was a median of 0.46 (0.48 6 0.28). The 50
patients enrolled were divided into two groups: 24 patients in
group A with second-day PGSR greater than 0.46 (median
0.64, range 0.50 to 1.25), and 26 patients in group B with
second-day PGSR less than or equal to 0.46 (median 0.27,
range 0.05 to 0.46).
Table 1 shows baseline characteristics of the two groups. No
significant differences were found between the two groups in
any of these characteristics. Table 2 summarizes clinical char-
acteristics and angiographic findings for each group. Between
the two groups there were no significant differences in the site
of culprit lesion, degree of collateral circulation immediately
before recanalization, RA ratio, cardiac index on day 2, time
from onset of symptoms to recanalization, frequency of coro-
nary angioplasty, peak value of creatine phosphokinase, ap-
Table 1. Baseline Patient Characteristics
MCE (day 2)
p ValueGroup A Group B
Number of patients 24 26
Age (yr) 63 6 12 68 6 12 0.11
Male 16 (67%) 16 (62%) 0.71
Systemic hypertension 13 (54%) 14 (54%) 0.98
Current smoker 11 (46%) 15 (58%) 0.41
Diabetes mellitus 7 (30%) 9 (35%) 0.69
Hyperlipidemia 10 (42%) 8 (31%) 0.42
Antecedent angina pectoris 16 (67%) 15 (58%) 0.52
Killip classification 0.31
Class 1 22 (92%) 20 (77%)
Class 2 1 (4%) 5 (19%)
Class 3 1 (4%) 1 (4%)
Class 4 0 0
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pearance of reperfusion arrhythmia, grade of TIMI flow on day
1, percent diameter stenosis on day 1 or percent diameter
stenosis on day 2. There were, however, significant differences
between them in hemodynamic variables and ECG findings.
There was no significant difference in administered medica-
tions between the two groups (Table 2). The enrolled patients
were followed up for a median of 21.8 months (range 3 days to
39 months). Table 3 shows the clinical outcomes of the study
patients. During the follow-up period, of the 24 patients in
group A, 1 died due to cerebrovascular accident immediately
after elective CABG. On the other hand, of the 26 patients in
group B, 1 died due to low cardiac output syndrome on the
third hospital day, 1 died suddenly due to ventricular fibrilla-
tion on the 15th hospital day and 1 died due to cardiac rupture
of oozing type on the fifth hospital day. No myocardial
reinfarctions or repeat admissions for congestive heart failure
occurred in group A, while two patients in group B suffered
myocardial reinfarction and two were readmitted for conges-
tive heart failure. Two patients in group A and three patients
in group B died of noncardiac causes. Seven patients in group
A underwent repeat interventions during the follow-up period.
Of the 26 group B patients, 10 underwent repeat interventions.
Thirty-five (83%) of 42 patients, with 3 patients who suffered
cardiac death and 5 who suffered noncardiac death excluded,
underwent repeat diagnostic catheterization during the remote
stage. Left ventriculograms could be obtained for 30 of the
patients who were alive at 12 months after recanalization. Left
ventricular ejection fraction and end-systolic ventricular vol-
ume were worse in group B than those in group A (Table 2)
(17).
As determined using the Cox proportional hazard model,
for major cardiac events the relative risk for the 26 group B
patients was 8.5-fold that of the 24 group A patients (chi-
square 5 3.96, p 5 0.05, 95% confidence interval [%CI] 1.03 to
69.9). For target lesion revascularization, the relative risk for
group B patients was 1.67-fold that of group A patients, but the
difference between groups in risk was not significant (chi-
square 5 1.08, p 5 0.29, 95% CI 0.63 to 4.41). For composite
cardiac events, the relative risk for group B patients was
2.13-fold that of group A patients, but again the difference
between groups in risk was not significant (chi-square 5 2.57,
p 5 0.10, 95% CI 0.85 to 5.35). One patient in group A and
seven in group B had major cardiac events over their clinical
course. If the cut-off value for prediction of major cardiac
events was set at a PGSR of 0.46, sensitivity, specificity,
positive predictive accuracy and negative predictive accuracy
were 87.5%, 54.8%, 26.9% and 95.8%, respectively. Both
specificity and positive predictive accuracy were too low for
prediction of cardiac events. In a stepwise variable selection
process for predicting major cardiac events, only the RA size
(chi-square 5 6.94, p 5 0.008) and the PGSR on day 2
(chi-square 5 3.94, p 5 0.046) were entered. Therefore, with
the vertical axis as PGSR and the horizontal axis as RA ratio,
patients who suffered major cardiac events were concentrated
Table 2. Patient Clinical Characteristics
MCE (day 2)
p ValueGroup A Group B
Culprit lesion (segment 6/segment 7) 12/12 9/17 0.27
Collateral circulation
(prerecanalization)
0.12
Grade 0 3 (12%) 9 (35%)
Grade 1 11 (46%) 10 (38%)
Grade 2 10 (42%) 7 (27%)
Risk area ratio 0.43 6 0.09 0.45 6 0.11 0.50
Systolic blood pressure on arrival
(mm Hg)
133 6 24 139 6 25 0.38
Pulmonary capillary wedge pressure
(mm Hg) (day 1)
9.8 6 3.7 13.6 6 7.8 0.03
Time from onset of symptoms to
recanalization (min)
440 6 209 441 6 270 0.98
Percutaneous transluminal coronary
angioplasty
20 (84%) 23 (88%) 0.60
Reperfusion arrhythmia 9 (38%) 12 (46%) 0.55
Re-elevation of ST-segment
immediately after recanalization
7 (29%) 15 (58%) 0.04
TIMI grade of flow (day 1) 0.19
Grade 2 3 (13%) 6 (23%)
Grade 3 21 (87%) 20 (77%)
Percent diameter stenosis (day 1) 31 6 22 29 6 20 0.73
Percent diameter stenosis (day 2) 43 6 24 37 6 21 0.35
Cardiac index (L/min/m2) (day 2) 3.4 6 0.8 3.2 6 0.8 0.37
Creatine phosphokinase (peak: IU/L) 3097 6 2385 3931 6 2231 0.21
Q-wave myocardial infarction 16 (67%) 24 (92%) 0.02
Left ventricular ejection fraction 44 6 9 35 6 18 0.03
(day 1) (n 5 24) (n 5 23)
Left ventricular ejection fraction 51 6 16 44 6 28 0.29
(day 28) (n 5 22) (n 5 20)
Left ventricular ejection fraction 56 6 12 45 6 14 0.04
(12 months after recanalization) (n 5 17) (n 5 13)
Left ventricular regional wall motion 22.71 6 0.62 23.16 6 0.49 0.01
(day 1) (n 5 24) (n 5 23)
Left ventricular regional wall motion 21.77 6 1.26 22.50 6 0.77 0.03
(day 28) (n 5 22) (n 5 20)
End-systolic volume (ml) 46 6 27 64 6 40 0.14
(12 months after recanalization) (n 5 17) (n 5 13)
Medications
Angiotensin converting enzyme
inhibitor
2 (8%) 4 (15%) 0.42
Beta-blocking agent 0 (0%) 1 (4%) 0.33
Calcium antagonist 18 (75%) 17 (65%) 0.56
Nicorandil 16 (67%) 13 (50%) 0.28
Table 3. Clinical Outcomes
MCE (day 2)
Group A Group B
Cardiac death 1 (4%) 3 (12%)
Nonfatal myocardial reinfarction 0 (0%) 2 (8%)
Repeat admission for congestive heart failure 0 (0%) 2 (8%)
Target lesion revascularization 7 (29%) 10 (38%)
Coronary artery bypass surgery 1 (4%) 1 (4%)
Noncardiac death 2 (8%) 3 (12%)
Restenosis 9 (38%) 10 (38%)
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among those for whom the RA ratio was high, and insufficient
recovery from microvascular impairment was found even one
day after reopening of the culprit lesion (Fig. 1,A). For the
group of all 50 examined patients, the median value of the RA
ratio was 0.45 (0.45 6 0.10). Patients (n 5 15) in whom the RA
ratio was .0.45 and for whom PGSR one day after recanali-
zation was #0.46 had a 10.7-fold relative risk for major cardiac
events after initial intervention (chi-square 5 7.95, p 5 0.005,
95% CI 2.06 to 55.8). They also had a 3.44-fold relative risk for
target lesion revascularization (chi-square 5 6.17, p 5 0.013,
95% CI 1.29 to 9.11) and a 3.69-fold relative risk for composite
cardiac events (chi-square 5 8.17, p 5 0.004, 95% CI 1.51 to
9.04) (Fig. 1).
Discussion
MCE one day after recanalization. Performance of serial
MCEs appears to be clinically useful since it enables not only
determination of both the location and size of the area at risk
for necrosis prior to recanalization but also observation of the
serial changes of restoration from microvascular impairment
within the initial RA (8,18).
Infarct size in experimental animal models tends to be
underestimated due to hyperemic response immediately after
recanalization (19). Immediately after recanalization, coronary
blood flow and volume can change rapidly. Microvascular
conditions might be significantly altered by hyperemic re-
sponse, microvascular spasm, microvascular embolism with
microthrombi and/or neutrophilic infiltration, interstitial
edema and/or hemorrhagic infarction in myocytes or other
factors (20). Recently, Kates et al. (21) showed that the
absence of perfusion abnormalities after reperfusion did not
rule out the presence of necrosis in dogs subjected to pro-
longed ischemia. Conversely, they showed that the presence of
a perfusion defect after reperfusion did not indicate the
presence of necrosis but rather abnormal microvascular re-
serve. The presence of hyperemia along with microvascular
impairment prevents exact determination of the infarct size
immediately after recanalization. We believe that determina-
tion of when and how microvascular integrity should be
estimated for accurate prediction of that in the convalescent
stage is a matter of greatest importance. We have already
reported that the greater part of rapid change in the injured
microvasculature occurred by one day after opening of the
IRA, and that microvascular integrity in the RA one day after
recanalization was closely related to that in the convalescent
stage (8). Microvascular integrity in the RA one day after
recanalization is relatively stable compared with that immedi-
ately after recanalization, and therefore its determination
using MCEs on the second hospital day is thought to be useful
for prediction of the clinical outcomes of patients who have
suffered acute MI.
Usefulness of MCE for predicting cardiac events. No
significant differences were found between our two groups in
age, Killip class, systolic blood pressure on arrival, grade of
TIMI flow on day 1, degree of collateral circulation immedi-
ately before recanalization or residual stenosis of the culprit
lesion on day 2. The 26 group B patients, however, had
significantly higher pulmonary wedge pressure levels before
recanalization, frequency of Q-wave infarction and rate of
occurrence of transient ST-segment re-elevation immediately
after recanalization than did the 24 group A patients. Further-
more, the patients in group B exhibited more serious impair-
ment of left ventricular ejection fraction and regional wall
motion abnormality on day 1 than did the patients in group A.
In the univariate analysis, the relationships between clinical
parameters and major cardiac events were as follows: pulmo-
Figure 1. Relationship between microvascular integrity within the
initial RA and clinical outcome. The horizontal axis is the RA ratio
before recanalization, while the vertical axis is PGSR one day after
recanalization. The upper panel (A) shows major cardiac events
(cardiac death, myocardial reinfarction or repeat admission for con-
gestive heart failure). Major cardiac events (solid circles) often
occurred for those patients whose RA ratio was high (.0.45) and
whose PGSR was relatively low (#0.46). Open triangles represent
patients for whom no major cardiac events were noted. The middle
panel (B) shows target lesion revascularizations (solid triangles). The
lower panel (C) shows composite cardiac events (solid squares).
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nary wedge pressure levels prior to recanalization (chi-
square 5 0.77, p 5 0.38), frequency of Q-wave infarction
(chi-square 5 0.37, p 5 0.54), rate of occurrence of transient
ST-segment re-elevation (chi-square 5 0.14, p 5 0.71), left
ventricular ejection fraction on day 1 (chi-square 5 3.01, p 5
0.08), PGSR on day 1 (chi-square 5 2.21, p 5 0.14), PGSR on
day 2 (chi-square 5 3.06, p 5 0.08) and RA size (chi-square 5
3.90, p 5 0.05). However, in the stepwise variable selection
process using the Cox hazard regression analysis model, only
the RA size (chi-square 5 6.94, p 5 0.008) and the PGSR on
day 2 (chi-square 5 3.94, p 5 0.046) among these variables
were entered from the regression equation on the basis of
significant computed probability in predicting major cardiac
events. The size of the RA is poorly reflected by measured
values of hemodynamic variables (12) and could not be
assessed with precision by the site of coronary occlusion within
a vessel during the acute stage of infarction (22). Furthermore,
prolonged myocardial ischemia causes myocardial stunning in
the acute stage as well as in the convalescent stage (20). Hence,
we were unable to predict with precision the viability of
myocardium in the RA using hemodynamic variables alone in
the acute stage. Our findings demonstrated that patients who
exhibit a high degree of microvascular damage within a
relatively large initial RA are at high risk for in-hospital
cardiac death due to low output syndromes, cardiac rupture,
myocardial reinfarction and repeat admission for congestive
heart failure, but that other patients with acceptable recovery
from microvascular impairment suffered no such events, with
the exception of one patient who underwent CABG in the
remote stage. Although the reason why a large extent of
microvascular impairment in the RA was associated with
myocardial reinfarction could not be determined from the
findings of our study alone, any of several mechanisms, such as
abrupt thrombus formation in the epicardial main coronary
artery with abolition of vascular remodeling (23) after large
MI, decrease in anterograde flow due to angiographically
undetectable flap formation and/or focal dissection in the
culprit lesion of the epicardial main coronary artery and
impaired coronary flow reserve due to sparse microvasculature
in the RA, might possibly have participated in reocclusion of
the initial IRA.
Our results agree with the finding that the size of the initial
RA as assessed by Technetium-99m sestamibi imaging is a
significant determinant of the likelihood of subsequent cardiac
death (4). Furthermore, our findings are consistent with re-
ports that patients who suffered a large MI affecting greater
than 40% of total left ventricular mass often suffered cardio-
genic shock or cardiac death due to low output syndrome (24)
and had very poor outcomes even if reperfusion therapy was
performed (4).
Comparison with previous studies. Few findings are avail-
able concerning the relationship between microvascular integ-
rity within the initial RA and subsequent clinical outcomes.
Recently Ito et al. (7) reported the in-hospital outcomes of
patients in whom significant no-reflow phenomenon within the
RA was detected by MCE. However, the difference in accuracy
of prediction of prognosis between MCE performed on day 1
and that performed on day 2 was not clear. Figure 2 shows
receiver operator characteristic curves for clinical outcomes
using PGSR values obtained by MCE on days 1 and 2. The
PGSR obtained by MCE one day after recanalization was
more useful for predicting major cardiac events than was the
PGSR obtained by MCE immediately after recanalization.
Further, in previous studies, intermediate-term prognoses
of patients with reperfused acute myocardial infarction were
not determined using both initial RA and microvascular integ-
rity after recanalization. In our study, the median value of
PGSR on day 1 was 0.33. The factor “RA ratio .0.45 and
PGSR on day 1 #0.33” was not an independent predictor of
major cardiac events (chi-square 5 1.46, p 5 0.23) but was an
independent predictor of composite cardiac events (chi-
square 5 4.31, p 5 0.038). On the other hand, the factor “RA
ratio .0.45 and PGSR on day 2 #0.46” was an independent
predictor of both major cardiac events (chi-square 5 8.23, p 5
0.004) and composite cardiac events (chi-square 5 10.72, p 5
0.001). Serial observation using MCE thus enables precise
prediction of the short- and intermediate-term prognoses of
patients with recanalized MI.
Study limitations. Several limitations affect interpretation
of the results of this study. First, the range of the 95th
percentile CI for cardiac events was too wide to permit
prediction of the clinical outcomes of patients with recanalized
MI. Further study may be needed with registration of a larger
number of patients. Second, we excluded Killip class 4 patients,
those with multivessel coronary artery disease and those with a
time to recanalization of greater than 24 h from the onset of
symptoms. Thus, some subjects who might have suffered severe
left ventricular dysfunction were excluded from the study.
Third, although MCE performed during pharmacologically
induced coronary hyperemia might permit accurate evaluation
of infarct size in experimental animal models, this adjunctive
procedure by itself inevitably affects not only the natural course
of microvascular impairment but also the clinical outcomes of
study patients. We therefore conducted the present study
Figure 2. Receiver operator characteristic curve for major cardiac
events (cardiac death, myocardial reinfarction or repeat admission for
congestive heart failure) using MCE on day 1 (open circles) and MCE
on day 2 (open squares). The area under the curve for day 2 is larger
than that for day 1. Myocardial contrast echocardiography on day 2
was more useful for predicting subsequent major cardiac events after
reperfusion therapy.
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without adjunctive pharmacologic hyperemia. Fourth, we
could not infuse the sonicated contrast media via the right
coronary artery in several patients. Therefore, although the
patients with Rentrop collateral grade III were excluded, the
size of initial RA might be overestimated in such patients.
Lastly, our MCE procedures required invasive techniques.
Further, sonicated ioxaglic acid is not a physiologic tracer like
sonicated albumin. It more likely acted as a deposit tracer.
Grayburn et al. (25) showed that MCE using intravenous
dodecafluoropentane accurately defined the myocardial area
at risk and infarct size, and had the potential for reliable,
noninvasive assessment of reperfusion following therapeutic
interventions. In the near future, serial MCEs using such
contrast media will enable interindividual variability in topog-
raphy in the region of ongoing microvascular impairment to be
determined, and will permit noninvasive determination of the
efficacy of reperfusion treatment.
Conclusions. This study was performed to determine
whether microvascular integrity in the RA for MI predicts the
clinical outcome of patients who have suffered their first acute
anterior or anteroseptal MI. Our findings demonstrated the
importance of determining the actual size of the RA just
before recanalization. Furthermore, both short- and
intermediate-term cardiac events tended to occur in those
patients with both large initial RA and inferior potential for
recovery from microvascular impairment even at one day after
recanalization. However, our procedure is invasive. In the near
future, use of intravenous echocardiographic contrast agents
may permit noninvasive evaluation of serial changes in the RA,
and prediction of the risk of cardiac events in patients who
have suffered acute MI.
References
1. Ross AM, Lundergan C, Thompson M, et al. The effects of tissue plasmin-
ogen activator, streptokinase, or both on coronary-artery patency, ventricular
function, and survival after acute myocardial infarction. New Engl J Med
1993;329:1615–22.
2. Clements IP, Christian TF, Higano ST, Gibbons RJ, Gersh BJ. Residual flow
to the infarct zone as a determinant of infarct size after direct angioplasty.
Circulation 1993;88:1527–33.
3. Maes A, Van DWF, Nuyts J, Bormans G, Desmet W, Mortelmans L.
Impaired myocardial tissue perfusion early after successful thrombolysis:
impact on myocardial flow, metabolism, and function at late follow-up.
Circulation 1995;92:2072–8.
4. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ,
Gibbons RJ. Infarct size after acute myocardial infarction measured by
quantitative tomographic 99m-Tc sestamibi imaging predicts subsequent
mortality. Circulation 1995;92:334–41.
5. Morishima I, Sone T, Mokuno S, et al. Clinical significance of no-reflow
phenomenon observed on angiography after successful treatment of acute
myocardial infarction with percutaneous transluminal coronary angioplasty.
Am Heart J 1995;130:239–43.
6. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately
after successful thrombolysis: a predictor of poor recovery of left ventricular
function in anterior myocardial infarction. Circulation 1992;85:1699–705.
7. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no reflow’
phenomenon: a predictor of complications and left ventricular remodeling in
reperfused anterior wall myocardial infarction. Circulation 1996;93:223–8.
8. Sakuma T, Hayashi Y, Shimohara A, Shindo T, Maeda K. Usefulness of
myocardial contrast echocardiography for the assessment of serial changes in
risk area in patients with acute myocardial infarction. Am J Cardiol
1996;78:1273–7.
9. Austen WG, Edwards JE, Frye RL, et al. AHA Committee Report: a
reporting system on patients evaluated for coronary artery disease: report of
Ad Hoc Committee for Grading of Coronary Artery Disease, Council on
Cardiovascular Surgery, American Heart Association. Circulation 1975;51:
7–40.
10. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral
circulation during sudden controlled coronary artery occlusion in human
subjects: a prospective study. Circulation 1986;74:469–76.
11. Reisner SA, Ong LS, Lichtenberg GS, et al. Myocardial perfusion imaging by
contrast echocardiography with use of intracoronary sonicated albumin in
humans. J Am Coll Cardiol 1989;14:660–5.
12. Kaul S. Risk area determination using myocardial contrast echocardiogra-
phy. Am J Card Imaging 1990;4:38–45.
13. Porter TR, D’Sa A, Pesko L, et al. Usefulness of myocardial contrast
echocardiography in detecting the immediate changes in anterograde blood
flow reserve after coronary angioplasty. Am J Cardiol 1993;71:893–6.
14. Ismail S, Jayaweera AR, Goodman NC, Camarano GP, Skyba DM, Kaul S.
Detection of coronary stenoses and quantification of the degree and spatial
extent of blood flow mismatch during coronary hyperemia with myocardial
contrast echocardiography. Circulation 1995;91:821–30.
15. Sheehan FH, Bolson EL, Dodge HT, et al. Advantages and applications of
the centerline method for characterizing regional ventricular function.
Circulation 1986;74:293–305.
16. Shapiro JR, Reisner SA, Amico AF, Kelly PF, Meltzer RS. Reproducibility
of quantitative myocardial contrast echocardiography. J Am Coll Cardiol
1990;15:602–9.
17. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarc-
tion. Experimental observations and clinical implications. Circulation 1990;
81:1161–72.
18. Ito H, Iwakura K, Oh H, et al. Temporal changes in myocardial perfusion
patterns in patients with reperfused anterior wall myocardial infarction.
Their relation to myocardial viability. Circulation 1995;91:656–62.
19. Villanueva FS, Camarano G, Ismail S, Goodman NC, Sklenar J, Kaul S.
Coronary reserve abnormalities in the infarcted myocardium: assessment of
myocardial viability immediately versus late after reflow by contrast echo-
cardiography. Circulation 1996;94:748–54.
20. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol
1993;21:537–45.
21. Kates MA, Meza MF, Barbee RW, et al. Potential clinical implications of
myocardial perfusion patterns immediately after reperfusion in a canine
model: a myocardial contrast echocardiography study. Am Heart J 1996;132:
303–13.
22. Haronian HL, Remetz MS, Sinusas AJ, et al. Myocardial risk area defined by
technetium-99m sestamibi imaging during percutaneous transluminal coro-
nary angioplasty: comparison with coronary angiography. J Am Coll Cardiol
1993;22:1033–43.
23. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. New
Engl J Med 1994;330:1431–8.
24. McCallister BD, Christian TF, Gersh BJ, Gibbons RJ. Prognosis of myocar-
dial infarctions involving more than 40% of the left ventricle after acute
reperfusion therapy. Circulation 1993;88:1470–5.
25. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral
intravenous myocardial contrast echocardiography using a 2% dodecaflu-
oropentane emulsion: identification of myocardial risk area and infarct size
in the canine model of ischemia. J Am Coll Cardiol 1995;26:1340–7.
897JACC Vol. 32, No. 4 SAKUMA ET AL.
October 1998:890–7 MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY
